Were people mentioning the details about the trial before or during the trial or only now due to negative results?
We are deff seeing low CBD only results not hitting the mark. People will complain about the trial setup, but from a regulation/ethics approval, you need generally start with the lowest and safest, and slowly move up the amount. Given we are still in early phases this will be low CBD > high CBD > THC/CBD mix etc.
drug development timelines are deff not for the faint of heart.
Ann: S3 Trial update, page-23
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $14.47M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.2¢ | 3.0¢ | $32.13K | 1.035M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1259746 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 53594 | 1 |
View Market Depth
| Last trade - 15.28pm 17/07/2024 (20 minute delay) ? |
| CAN (ASX) Chart |